Publicacions en col·laboració amb investigadors/es de Hospital Universitari de Bellvitge (14)

2018

  1. Prevention and treatment of tuberculosis infection in candidates for biologic therapy: A multidisciplinary consensus statement adapted to the dermatology patient

    Actas Dermo-Sifiliograficas, Vol. 109, Núm. 7, pp. 584-601

2017

  1. Outbreak of brainstem encephalitis associated with enterovirus-A71 in Catalonia, Spain (2016): a clinical observational study in a children's reference centre in Catalonia

    Clinical Microbiology and Infection, Vol. 23, Núm. 11, pp. 874-881

2016

  1. Consensus Document on Prevention and Treatment of Tuberculosis in Patients for Biological Treatment

    Archivos de Bronconeumologia, Vol. 52, Núm. 1, pp. 36-45

2015

  1. Neumonía adquirida en la comunidad: tratamiento ambulatorio y prevención

    Anales de Pediatria, Vol. 83, Núm. 6, pp. 439.e1-439.e7

2014

  1. Status of pediatric hospital medicine in Spain: A report by the Spanish Pediatric Hospital Medicine Society (SEPHO)

    Anales de Pediatria, Vol. 81, Núm. 5, pp. 326.e1-326.e8

2013

  1. Analysis of human metapneumovirus and human bocavirus viral load

    Pediatric Infectious Disease Journal, Vol. 32, Núm. 9, pp. 1032-1034

  2. Clinical risk factors are more relevant than respiratory viruses in predicting bronchiolitis severity

    Pediatric Pulmonology, Vol. 48, Núm. 5, pp. 456-463

  3. Risk factors for invasive pneumococcal disease in a community with a high proportion of non vaccine serotypes

    Vaccine, Vol. 31, Núm. 6, pp. 960-966

2012

  1. Comparison of an in-house real-time RT-PCR assay with a commercial assay for detection of enterovirus RNA in clinical samples

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 31, Núm. 5, pp. 715-719

2011

  1. 2009 influenza a H1N1 infections: Delays in starting treatment with oseltamivir were associated with a more severe disease

    Pediatric Infectious Disease Journal, Vol. 30, Núm. 7, pp. 622-625

  2. Effectiveness of 7-valent pneumococcal conjugate vaccine in the prevention of invasive pneumococcal disease in children aged 7-59 months. A matched case-control study

    Vaccine, Vol. 29, Núm. 48, pp. 9020-9025

2010

  1. Tos ferina, una entidad persistente

    Enfermedades Infecciosas y Microbiologia Clinica

2006

  1. Aumento de la resistencia a macrólidos mediada por metilasas en Streptococcus pyogenes en un hospital pediátrico de Barcelona

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 24, Núm. 1, pp. 26-28

1997

  1. Sindrome de Ohtahara: Una forma de epilepsia edad-dependiente

    Revista de Neurologia, Vol. 25, Núm. 138, pp. 212-214